Christoph Losem
Grevenbroich, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO study.
Journal: Leukemia & lymphoma
Published: December 10, 2024
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Journal: Annals of hematology
Published: September 30, 2023
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
Journal: International journal of cancer
Published: July 07, 2023
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Journal: Current medical research and opinion
Published: September 01, 2022
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
Journal: Journal of bone oncology
Published: October 06, 2021
Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 29, 2021
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 07, 2020
Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.
Journal: Future oncology (London, England)
Published: July 09, 2019
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR.
Journal: Current medical research and opinion
Published: December 18, 2018
AVAiLABLE NIS - AVASTIN® in lung cancer treatment in routine oncology practice in Germany.
Journal: BMC cancer
Published: August 03, 2018
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).
Journal: European journal of haematology
Published: April 03, 2018
Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials.
Journal: Leukemia research
Published: October 27, 2017
Last Updated: 09/26/2026